UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000010363
Receipt No. R000011961
Scientific Title A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Date of disclosure of the study information 2013/04/01
Last modified on 2019/12/18 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Acronym A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Scientific Title A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Scientific Title:Acronym A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Region
Japan

Condition
Condition advanced or recurrent non-small cell lung cancer
Classification by specialty
Pneumology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To determine whether survival after diagnosis is associated with opiod dosing and other factors.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes how opioid influenced survival after diagnosis
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria non-small cell lung cancer
Key exclusion criteria nothing in particular
Target sample size

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Hasegawa Takaaki
Organization Gifu municipal hospital
Division name Department of respiratory and medical oncology
Zip code
Address 7-1 KASHIMA-CHO GIFU-SHI GIFU
TEL
Email

Public contact
Name of contact person
1st name
Middle name
Last name
Organization Gifu municipal hospital
Division name Department of respiratory and medical oncology
Zip code
Address 7-1 KASHIMA-CHO GIFU-SHI GIFU
TEL
Homepage URL
Email

Sponsor
Institute Gifu municipal hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 04 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2013 Year 01 Month 30 Day
Date of IRB
2013 Year 01 Month 30 Day
Anticipated trial start date
2013 Year 04 Month 01 Day
Last follow-up date
2016 Year 07 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information multiple regression analysis to determine the extent to which opioid dosing or other clinical factors (the independent variables:histology, Stage, ECOG PS, Sex) are associated with time till death after diagnosis, prospective study, complete survey in a single institute.

Management information
Registered date
2013 Year 03 Month 29 Day
Last modified on
2019 Year 12 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011961